Skip to main content
Back to feed
HealthEmergingMedium
4.7

Stopping GLP-1 drugs linked to higher heart attack, stroke, death risk

New research from Washington University suggests that discontinuing GLP-1 medications (Ozempic, Wegovy, Mounjaro, Zepbound) may increase cardiovascular risk. The finding is based on observational data and requires confirmation. If validated, it could influence prescribing and patient adherence, with potential public-health and market implications.

Rzeczpospolitaabout 4 hours agoUSCredibility 29%View source

Score Breakdown

Mosaic Score4.7
Confidence0.3
Significance0.5
Source credibility0.3

Intelligence Tags

#glp-1#cardiovascular#drug-safety#pharmaceuticals#public-health

Locations

St. LouisWashington

Entities

country
Source

Related signals

8 found